Low-fluence rate, long duration photodynamic therapy in glioma mouse model using organic light emitting diode (OLED).

BACKGROUND The treatment of gliomas poses significant clinical challenges due to resistance to chemo and radiation therapy, and treatment side effects. Metronomic photodynamic therapy (mPDT), which involves long treatment time with low fluence rate and multiple or continuous photosensitizer administrations, has potential in treating gliomas without threatening the quality of life and has been demonstrated in rats and rabbits. mPDT in small animals such as mouse is not yet shown due to lack of lightweight illumination device for long periods of time. METHODS We presented low fluence rate (3mW/cm(2)) and long duration (3.7h) PDT treatment in a nude mouse model of human glioblastoma by using organic light emitting diode (OLED) with single dose of 5-aminolevulinic acid (ALA) administration as photosensitizer. Tumor volume was measured using bioluminescent imaging and the animal survival time was recorded. Additionally, we have performed limited PDT dosimetric measurements of PpIX fluorescence, tumor oxygenation and hemoglobin concentration in 3 PDT mice. RESULTS For animals with similar pre- and immediate post-light tumor volume, the averaged total survival time of PDT mice is 40.5±9.2 days that are significantly longer than the control mice (26.0±2.0 days). The post-light survival time of PDT mice is 14.3±5.9 days that are marginally longer than the control group (8.0±0.0 days). In the dosimetric measurement, good maintenance of PpIX fluorescence in one PDT mouse has relatively improved survival time, compared with the other two PDT mice (i.e., 24 days versus 16 and 17 days). CONCLUSIONS This pilot study demonstrated the feasibility of low-fluence rate and long treatment time of ALA-PDT using OLED without anesthetization of animals. The response of PDT treated animals with similar pre- and post-light tumor volume is encouraging to show a longer survival time than the controls. The dosimetric indices such as photosensitizer fluorescence and tissue oxygenation would help understand the possible treatment barriers for further improvement of treatment plans.

[1]  S. Chiou,et al.  A Comparative Study of Primary and Recurrent Human Glioblastoma Multiforme Using the Small Animal Imaging and Molecular Expressive Profiles , 2013, Molecular Imaging and Biology.

[2]  Henry Hirschberg,et al.  Repetitive photodynamic therapy of malignant brain tumors. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[3]  Nasser N Peyghambarian,et al.  Application of Screen Printing in the Fabrication of Organic Light‐Emitting Devices , 2000 .

[4]  H. Woo,et al.  Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. , 2013, Cell reports.

[5]  L. Lilge,et al.  Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development , 2005, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[6]  Lothar Lilge,et al.  Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶ , 2004, Photochemistry and photobiology.

[7]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[8]  T. Foster,et al.  Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. , 1995, Cancer research.

[9]  François Guillemin,et al.  Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies. , 2014, Cancer treatment reviews.

[10]  Chi-Hung Lin,et al.  Diffuse reflectance spectroscopy detects increased hemoglobin concentration and decreased oxygenation during colon carcinogenesis from normal to malignant tumors. , 2009, Optics express.

[11]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[12]  Li-Hsin Chen,et al.  Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response , 2011, Radiation oncology.

[13]  Gurmit Singh,et al.  Metronomic PDT and cell death pathways. , 2010, Methods in molecular biology.

[14]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[15]  W. Cavenee,et al.  Heterogeneity maintenance in glioblastoma: a social network. , 2011, Cancer research.

[16]  Eli Glatstein,et al.  Effect of Photosensitizer Dose on Fluence Rate Responses to Photodynamic Therapy † , 2007, Photochemistry and photobiology.

[17]  B. Wilson,et al.  Interstitial in vivo ALA-PpIX mediated metronomic photodynamic therapy (mPDT) using the CNS-1 astrocytoma with bioluminescence monitoring. , 2007, Photodiagnosis and photodynamic therapy.

[18]  Q. Gong,et al.  Optical design for improving optical properties of top-emitting organic light emitting diodes , 2013 .

[19]  M. Sam Eljamel,et al.  ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial , 2008, Lasers in Medical Science.

[20]  M. Westphal,et al.  Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2 , 2008, Clinical Cancer Research.

[21]  M. Vogelbaum,et al.  Current concepts and newer developments in the treatment of malignant gliomas. , 2009, Indian journal of cancer.

[22]  Y. Wong,et al.  Quantitative physiology and immunohistochemistry of oral lesions. , 2013, Biomedical optics express.

[23]  Ping Zhao,et al.  A highly invasive human glioblastoma pre-clinical model for testing therapeutics , 2008, Journal of Translational Medicine.

[24]  T. Busch,et al.  Local physiological changes during photodynamic therapy , 2006, Lasers in surgery and medicine.